Page contents Back to list Full notification Final report General information GMO characterization European Commission administrative Information Return to search
Full notification Final report - General information Notification Number B/NL/22/003 Member State to which the notification was sent Netherlands Date of acknowledgement from the Member State Competent Authority 14/07/2022 Title of the Project Multicenter, Open-label, Adaptive Design Phase I Trial with Genetically Modified T-cells Carrying Universal Chimeric Antigen Receptors (UniCAR02-T) in Combination with CD123 Target Module (TM123) for the Treatment of Patients with Hematologic and Lymphatic Malignancies Positive for CD123 Proposed period of release: 01/01/2023 to 30/06/2024 Name of the Institute(s) or Company(ies) Erasmus MC, Erasmus MC s-Gravendijkwal 230 Afdeling Urologie Rotterdam 3015 CE The Netherlands
Is the same GMO been notified elsewhere by the same notifier? Yes:
Germany;
Has the same GMO been notified elsewhere by the same notifier? No GMO characterization GMO is a: RNA Virus Identity of the GMO: Genus: Gamma-Retrovirus Species: Moloney murine leukemia virus  Information relating to the recipient or parental organisms from which the GMO is derived Common Name: MoMuLV Genus: Gamma-Retrovirus Species: Moloney Murine Leukemia Subspecies: Oncovirinae type C Strain: Pathovar: European Commission administrative Information Consent given by the Member State Competent Authority: Yes
07/27/2022
Close
Select your language
English